home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

3rd Annual Inhalation & Respiratory Drug Delivery USA Congress

 
  September 30, 2019  
     
 
Oxford Global, Hilton San Diego Mission Valley, 901 Camino del Rio South, San Diego, CA, 92108, USA,
17 - 18 March 2020


Over 300 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions.

Over 20 presentations and case studies focussing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products.

Including 2 interactive streams:

Development & Formulation of Inhaled Therapies

Inhalation Devices & Analytics

 

*View Agenda: https://bit.ly/2nUeUNO

 

This event is co-located with the 3rd Annual Formulation & Drug Delivery USA Congress

 

For more information, please contact e.hawkings@oxfordglobal.co.uk

 

Go Social: Join our Formulation & Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress & join the conversation at #FDDUS19


 
  *2020 Live Webinar*

‘The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence’

Hosted by Paul Upham, Head, Smart Devices, Genentech

Wed, Jan 15, 2020 4:30 PM - 5:30 PM GMT

Register for Free: https://bit.ly/2kK3BqB

 
 
Organized by: OxfordGlobal
Invited Speakers:

Christy Cappelletti, Director, Clinical Development, AstraZeneca

Yaping Zhu, Executive Director, Device Development & Inhalation Development, Sandoz

George Cusatis, Associate Director, Device & Digital Health, Merck

Samir Shah, Associate Director, Respiratory and Combination Regulatory Affairs, Teva

Paul Upham, Head, Smart Devices, Genentech

Larry Brown, Chief Scientific Officer & Executive Vice President, Noveome

Carlos Schuler, Chief Operating and Technical Officer, InCarda Therapeutics

Stephen Pham, Vice President Product Development, Avalyn Pharma

 
Deadline for Abstracts: N/A
 
Registration: https://eu.eventscloud.com/ereg/index.php?eventid=200192946&
E-mail: g.alonso@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.